MML Investors Services
JANX icon

MML Investors Services’s Janux Therapeutics JANX Stock Holding History

MML Investors Services’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Sell
17,138
-3,472
-17% -$50.3K ﹤0.01% 2914
2026
Q1 		$286K Buy
+20,610
New +$283K ﹤0.01% 2589

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

MML Investors Services's JANX Position: Q2 2026 in Review

MML Investors Services reduced its Janux Therapeutics (JANX) stake by 17% in Q2 2026, selling an estimated $50.3K and leaving 17,138 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2914.

MML Investors Services first reported a position in JANX in Q1 2026 and has held it in 2 quarters since. The position peaked at $286K in Q1 2026. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • MML Investors Services held 17,138 shares of Janux Therapeutics worth $263K as of Q2 2026.
  • MML Investors Services sold 3,472 Janux Therapeutics shares in Q2 2026, an estimated $50.3K.
  • Janux Therapeutics made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2914 holding.
  • MML Investors Services first reported a position in Janux Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • MML Investors Services's Janux Therapeutics position peaked at $286K in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.